gabapentin has been researched along with Aggression in 19 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Aggression: Behavior which may be manifested by destructive and attacking action which is verbal or physical, by covert attitudes of hostility or by obstructionism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To provide a qualitative, systematic update and review of the pharmacology, pharmacokinetics, efficacy in mood disorders, adverse effects, and costs of lamotrigine." | 8.81 | Lamotrigine update and its use in mood disorders. ( Hurley, SC, 2002) |
| "The possible role of GABA in human aggression was evaluated by administering gabapentin to subjects with and without a history of conduct disorder and comparing the effects on laboratory measures of aggression and escape." | 7.72 | Acute effects of gabapentin on laboratory measures of aggressive and escape responses of adult parolees with and without a history of conduct disorder. ( Cherek, DR; Lane, SD; Pietras, CJ; Tcheremissine, OV, 2004) |
| "In a 24-patient case series from retrospective chart review, the authors examined the use of gabapentin for the treatment of aggressive and agitated behaviors in nursing home patients with a DSM-IV diagnosis of dementia." | 7.70 | A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias. ( Hawkins, JW; Peyser, CE; Sheikh, JI; Tinklenberg, JR; Yesavage, JA, 2000) |
| "Gabapentin (GBP) is a new antiepileptic drug (AED) approved for adjunctive treatment of complex partial seizures with or without seizures secondarily generalization in adults." | 7.69 | Gabapentin associated with aggressive behavior in pediatric patients with seizures. ( Lo, W; Nahata, MC; Tallian, KB; Tsao, CY, 1996) |
| "Following PRISMA guidelines, we systematically reviewed evidence for gabapentin and pregabalin against BPSD symptoms of agitation or aggression in any dementia, using six databases (Pubmed, CINHL, PsychINFO, HealthStar, Embase, and Web of Science)." | 5.01 | Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report. ( Abdool, PS; Asmer, S; Bolea-Alamanac, BM; Davies, SJC; Supasitthumrong, T; Woo, VL, 2019) |
| "To review and summarize the currently available data on the use of anticonvulsant mood stabilizers (carbamazepine, valproic acid, gabapentin, lamotrigine, topiramate) in the treatment of behavioral and psychological symptoms of dementia (BPSD); to determine whether these medications can be recommended for routine clinical use." | 4.84 | Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review. ( Konovalov, S; Muralee, S; Tampi, RR, 2008) |
| "To provide a qualitative, systematic update and review of the pharmacology, pharmacokinetics, efficacy in mood disorders, adverse effects, and costs of lamotrigine." | 4.81 | Lamotrigine update and its use in mood disorders. ( Hurley, SC, 2002) |
| "The possible role of GABA in human aggression was evaluated by administering gabapentin to subjects with and without a history of conduct disorder and comparing the effects on laboratory measures of aggression and escape." | 3.72 | Acute effects of gabapentin on laboratory measures of aggressive and escape responses of adult parolees with and without a history of conduct disorder. ( Cherek, DR; Lane, SD; Pietras, CJ; Tcheremissine, OV, 2004) |
| "In a 24-patient case series from retrospective chart review, the authors examined the use of gabapentin for the treatment of aggressive and agitated behaviors in nursing home patients with a DSM-IV diagnosis of dementia." | 3.70 | A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias. ( Hawkins, JW; Peyser, CE; Sheikh, JI; Tinklenberg, JR; Yesavage, JA, 2000) |
| "Gabapentin (GBP) is a new antiepileptic drug (AED) approved for adjunctive treatment of complex partial seizures with or without seizures secondarily generalization in adults." | 3.69 | Gabapentin associated with aggressive behavior in pediatric patients with seizures. ( Lo, W; Nahata, MC; Tallian, KB; Tsao, CY, 1996) |
| " Results of the study indicate that 1) Early SIS could be considered as an animal model of psychosocial stress to investigate the psychiatric comorbidities in seizure disorders, 2) Chronic administration of low dose GBP prevented the shaping of behavioral abnormalities in adulthood, 3) Chronic administration of low dose GBP produced no negative behavioral effects in socially conditioned mice suggesting the safety of the drug, 4) Gabapentin at low doses may be considered as an agent for management of epilepsy in individuals with psychiatric comorbidities." | 1.46 | Protective effects of gabapentin against the seizure susceptibility and comorbid behavioral abnormalities in the early socially isolated mice. ( Amini-Khoei, H; Amiri, S; Ghazi-Khansari, M; Haj-Mirzaian, A; Mohsenzadeh, A; Olson, CO; Rahimi-Balaei, M; Rastegar, M; Razmi, A; Shirzadian, A; Zarrindast, MR, 2017) |
| "Early treatment of epilepsy is warranted to avoid possible severe consequences." | 1.39 | Epilepsy and brain injury: a case report of a dramatic neuropsychiatric vicious circle. ( Angeletti, G; Carbonetti, P; Del Casale, A; Fensore, C; Ferracuti, S; Girardi, P; Kotzalidis, GD; Lazanio, S; Muzi, A; Rapinesi, C; Savoja, V; Scatena, P; Serata, D; Tatarelli, R, 2013) |
| " Chronic administration of the synthetic gonadotropin (luteinising hormone) releasing hormone analogue, goserelin, reduces testosterone activity." | 1.33 | Gonadotrophin-releasing hormone agonist treatment of aggression in Alzheimer's disease: a case report. ( Raskind, MA; Rosin, RA, 2005) |
| " Optimal dosing remains unclear." | 1.31 | Gabapentin for treatment of behavioral and psychological symptoms of dementia. ( Miller, LJ, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 9 (47.37) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Kruszka, M | 1 |
| Graff, E | 1 |
| Medam, T | 1 |
| Masson, S | 1 |
| Supasitthumrong, T | 1 |
| Bolea-Alamanac, BM | 1 |
| Asmer, S | 1 |
| Woo, VL | 1 |
| Abdool, PS | 1 |
| Davies, SJC | 1 |
| Calder, CD | 1 |
| Cooney, C | 1 |
| Murphy, S | 1 |
| Tessema, H | 1 |
| Freyne, A | 1 |
| Rapinesi, C | 1 |
| Del Casale, A | 1 |
| Serata, D | 1 |
| Kotzalidis, GD | 1 |
| Scatena, P | 1 |
| Muzi, A | 1 |
| Lazanio, S | 1 |
| Savoja, V | 1 |
| Carbonetti, P | 1 |
| Fensore, C | 1 |
| Ferracuti, S | 1 |
| Angeletti, G | 1 |
| Tatarelli, R | 1 |
| Girardi, P | 1 |
| Amiri, S | 1 |
| Haj-Mirzaian, A | 1 |
| Amini-Khoei, H | 1 |
| Razmi, A | 1 |
| Shirzadian, A | 1 |
| Rahimi-Balaei, M | 1 |
| Olson, CO | 1 |
| Mohsenzadeh, A | 1 |
| Rastegar, M | 1 |
| Zarrindast, MR | 1 |
| Ghazi-Khansari, M | 1 |
| Cherek, DR | 1 |
| Tcheremissine, OV | 1 |
| Lane, SD | 1 |
| Pietras, CJ | 1 |
| Rosin, RA | 1 |
| Raskind, MA | 1 |
| Konovalov, S | 1 |
| Muralee, S | 1 |
| Tampi, RR | 1 |
| Demily, C | 1 |
| Franck, N | 1 |
| Wolf, SM | 1 |
| Shinnar, S | 1 |
| Kang, H | 1 |
| Gil, KB | 1 |
| Moshé, SL | 1 |
| Lee, DO | 1 |
| Steingard, RJ | 1 |
| Cesena, M | 1 |
| Helmers, SL | 1 |
| Riviello, JJ | 1 |
| Mikati, MA | 1 |
| Tallian, KB | 1 |
| Nahata, MC | 1 |
| Lo, W | 1 |
| Tsao, CY | 1 |
| Low, RA | 1 |
| Brandes, M | 1 |
| Hawkins, JW | 1 |
| Tinklenberg, JR | 1 |
| Sheikh, JI | 1 |
| Peyser, CE | 1 |
| Yesavage, JA | 1 |
| Miller, LJ | 1 |
| Pinninti, NR | 1 |
| Mahajan, DS | 1 |
| Hurley, SC | 1 |
| Biancosino, B | 1 |
| Facchi, A | 1 |
| Marmai, L | 1 |
| Grassi, L | 1 |
3 reviews available for gabapentin and Aggression
| Article | Year |
|---|---|
Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report.
Topics: Aged; Aggression; Alzheimer Disease; Calcium Channel Blockers; Dose-Response Relationship, Drug; Gab | 2019 |
Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review.
Topics: Aggression; Amines; Anticonvulsants; Carbamazepine; Cognition Disorders; Cyclohexanecarboxylic Acids | 2008 |
Lamotrigine update and its use in mood disorders.
Topics: Acetates; Aggression; Amines; Antidepressive Agents; Bipolar Disorder; Cyclohexanecarboxylic Acids; | 2002 |
2 trials available for gabapentin and Aggression
| Article | Year |
|---|---|
Clinical evaluation of the effects of a single oral dose of gabapentin on fear-based aggressive behaviors in cats during veterinary examinations.
Topics: Aggression; Analgesics; Animals; Cats; Double-Blind Method; Fear; Gabapentin; Physical Examination | 2021 |
Gabapentin toxicity in children manifesting as behavioral changes.
Topics: Acetates; Affect; Aggression; Amines; Anticonvulsants; Behavior; Child; Cyclohexanecarboxylic Acids; | 1995 |
14 other studies available for gabapentin and Aggression
| Article | Year |
|---|---|
Animal Behavior Case of the Month.
Topics: Aggression; Animals; Anti-Anxiety Agents; Behavior Therapy; Behavior, Animal; Dogs; Environment; Fea | 2019 |
Use of low-dose gabapentin for aggressive behavior in vascular and Mixed Vascular/Alzheimer Dementia.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Amines; Cyclohexanecarboxylic Acids; Dementi | 2013 |
Epilepsy and brain injury: a case report of a dramatic neuropsychiatric vicious circle.
Topics: Accidents, Traffic; Aggression; Amines; Anterior Temporal Lobectomy; Anticonvulsants; Brain Injuries | 2013 |
Protective effects of gabapentin against the seizure susceptibility and comorbid behavioral abnormalities in the early socially isolated mice.
Topics: Aggression; Amines; Animals; Anticonvulsants; Anxiety; Behavior, Animal; Comorbidity; Cyclohexanecar | 2017 |
Acute effects of gabapentin on laboratory measures of aggressive and escape responses of adult parolees with and without a history of conduct disorder.
Topics: Acetates; Adult; Aggression; Amines; Conduct Disorder; Cyclohexanecarboxylic Acids; Escape Reaction; | 2004 |
Gonadotrophin-releasing hormone agonist treatment of aggression in Alzheimer's disease: a case report.
Topics: Aged; Aggression; Alzheimer Disease; Amines; Antipsychotic Agents; Benzodiazepines; Cyclohexanecarbo | 2005 |
Gabapentin for ultra resistant schizophrenia with aggressive behavior.
Topics: Adult; Aggression; Amines; Anticonvulsants; Antipsychotic Agents; Cyclohexanecarboxylic Acids; Drug | 2008 |
Behavioral side effects of gabapentin in children.
Topics: Acetates; Aggression; Akathisia, Drug-Induced; Amines; Anticonvulsants; Attention Deficit Disorder w | 1996 |
Gabapentin associated with aggressive behavior in pediatric patients with seizures.
Topics: Acetates; Adolescent; Age Factors; Aggression; Amines; Anticonvulsants; Child; Child Behavior Disord | 1996 |
Gabapentin for the management of agitation.
Topics: Acetates; Aggression; Amines; Cyclohexanecarboxylic Acids; GABA Agonists; Gabapentin; gamma-Aminobut | 1999 |
A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias.
Topics: Acetates; Aged; Aged, 80 and over; Aggression; Amines; Antimanic Agents; California; Cyclohexanecarb | 2000 |
Gabapentin for treatment of behavioral and psychological symptoms of dementia.
Topics: Acetates; Aggression; Amines; Behavior; Cyclohexanecarboxylic Acids; Dementia, Vascular; Excitatory | 2001 |
Gabapentin-associated aggression.
Topics: Acetates; Adult; Aggression; Amines; Antimanic Agents; Bipolar Disorder; Cyclohexanecarboxylic Acids | 2001 |
Gabapentin treatment of impulsive-aggressive behaviour.
Topics: Acetates; Adult; Aggression; Amines; Antimanic Agents; Bipolar Disorder; Cyclohexanecarboxylic Acids | 2002 |